. 2023 Apr 8;149(10):8117–8129. doi: 10.1007/s00432-023-04735-w

Table 3.

Previous treatments

	Mulvihill et al. (2001)	Hecht et al. (2003)	Lee et al. (2020)	Barton et al. (2021)	Bazan-Peregrino et al. (2021)	Garcia-Carbonero et al. (2022)^a
	Mulvihill et al. (2001)	Hecht et al. (2003)	Lee et al. (2020)	Barton et al. (2021)	Bazan-Peregrino et al. (2021)	Part 2	Part 3
Previous chemotherapy (%)	43.4	38.1	0.0	0.0	12.5	NR	NR
Previous radiation (%)	17.4	NR	0.0	0.0	0.0	NR	NR
Previous surgery (%)	52.2	NR	0.0	0.0	12.5	NR	NR
No previous treatment (%)	26.1	NR	100.0	100.0	75.0%	66.6	85.7

^aIn Garcia-Carbonero et al. (2022), 33.3% of patients in Part 2 and 14.3% of patients in Part 3 had previously received antineoplastic treatment, though the type is not reported